Weisen begins exports to the Middle East… supply contract with the largest medical company
[이데일리 나은경 기자] Waysen, an artificial intelligence (AI) medtech company, announced on the 14th that it signed a strategic sales agreement for its medical AI solutions and healthcare products with Megamind, the largest medical company in the Middle East, located in Saudi Arabia. Waysen Nam Ki-hyuk, in charge, and Megamind Chairman Hamza is signing the contract. (Photo = Waysen)
Through this contract, Waysen will develop artificial intelligence gastric and colonoscopy software ‘Waymed Endo’ and artificial intelligence respiratory self-screening service ‘Waymed Corp’ in the Middle East market based on Megamind’s network, which holds a high market share in the Middle East medical market. Introduction begins in earnest.
Megamind is a specialized company located in Saudi Arabia and owns 11 group hospitals in the Middle East. Currently, a digital project is in progress with about 40 Saudi government medical institutions and private medical institutions. Every year, we receive orders for projects to build data centers for 15 to 25 hospitals in the Middle East, and we are playing a major role in leading the digital innovation of medical institutions in the Middle East through telemedicine and digitization of medical data in the region in cooperation with the government and medical institutions. .
In particular, it is known that this strategic sales agreement will include Waysen’s flagship product lineup, Waymed Endo and Waymed Corp, as well as cooperation with the next product lineup to enter the Middle East market. The company expects that it will be able to create new export opportunities in the Middle East medical market, where K-medical AI products are gaining momentum.
Kim Gyeong-nam, CEO of Waysen, said, “Starting with this contract, the 11 hospitals in the Middle East owned by Megamind will begin using ‘Waymed Endo,’ an artificial intelligence gastric and colonoscopy software, within the year at the earliest.” He added, “Already in some parts of the Middle East. “As there is positive feedback from medical staff regarding the actual use of Waymed Endo in hospitals, we want to take advantage of this opportunity to create a successful case in the Middle East market,” he said.
Megamind Chairman Hamza Baterjee said, “As the desire for high-quality endoscopic medical services and interest in respiratory health are increasing in the Middle East market, we are confident that the value of Waysen’s medical AI technology will be successfully established in the Middle East market. “So we signed this contract,” he said.
2024-02-13 23:29:47
#Weisen #begins #exports #Middle #East.. #supply #contract #largest #medical #company
